Greederboard
Official portrait of Tina Smith

Tina Smith

D Democrat · Senator, Minnesota
26
Moderate self-dealing
4/6 components have data
#70 of 193 scored

Senator Tina Smith (D-MN), who has announced she will not seek reelection in 2026, has faced the most accountability scrutiny over household stock trading. Her husband Archie Smith, a longtime medical-device investor, made six-figure purchases in medical-technology firms (e.g., Tactile Systems, Artivion) in late 2023 while Smith sits on the Senate HELP (Health) Committee; the household portfolio reportedly returned 35.4% in 2023 versus the S&P 500's ~24.8%, and one med-tech stock surged ~48% shortly after purchase. Smith states she has no role in or knowledge of her husband's investment decisions, and no insider-trading charges or findings have been made — the concerns are conflict-of-interest and timing allegations raised by media and political critics, not proven self-dealing. On other dimensions she shows a clean record: a low 2.0% missed-vote rate, no documented FEC personal-use or revolving-door findings, and net-worth growth largely attributable to her husband's pre-existing investment career rather than office tenure.

Public record

In Congress since
2018
Committees
Agriculture, Nutrition, and Forestry
Banking, Housing, and Urban Affairs
Finance
Indian Affairs
Missed votes, 119th Congress
4.6% (42 of 915; median member 1.9%)
Campaign money, 2025–26 cycle
$49K raised · 47% from PACs & committees · $201K cash on hand FEC ↗

The stock-trading ban

Senate cloture on H.R. 7008, Sep 30, 2026
No
Cosponsored a ban bill
None

H.R. 7008 bans new stock purchases by members, spouses and dependents; it doesn't force sales of existing holdings. The Senate vote was on the version paired with the SAVE Act, which is why no Democrat voted yes. Full breakdown →

Disclosed stock trades

11trades since Jan 2025
0buys
11sells
0filed past 45 days
$1.0M–$2.5Mdisclosed value range

Most-traded: PODD ×2 · DXCM ×2 · BRK.B ×2 · MMM ×1 · HBAN ×1 · PEP ×1 · GIS ×1

TradedFiledOwnerAssetTypeAmount
May 7, 2026May 10, 2026SpousePODD Insulet Corporation - Common StockSell$100,001 - $250,000filing ↗
May 7, 2026May 10, 2026SpouseDXCM DexCom, Inc. - Common StockSell$100,001 - $250,000filing ↗
Apr 29, 2026May 10, 2026SpousePODD Insulet Corporation - Common StockPartial sell$100,001 - $250,000filing ↗
Apr 29, 2026May 10, 2026SpouseDXCM DexCom, Inc. - Common StockPartial sell$100,001 - $250,000filing ↗
Mar 31, 2026Apr 2, 2026SpouseMMM 3M Company Common StockSell$50,001 - $100,000filing ↗
Mar 31, 2026Apr 2, 2026SpouseBRK.B Berkshire Hathaway Inc. New Common StockSell$100,001 - $250,000filing ↗
Jan 27, 2026Jan 30, 2026SpouseBRK.B Berkshire Hathaway Cl BPartial sell$100,001 - $250,000filing ↗
Jan 27, 2026Jan 30, 2026SpouseMRSH - Marsh & McLennan Companies, Inc. Common StockSell$50,001 - $100,000filing ↗
Nov 21, 2025Nov 26, 2025SpouseHBAN Huntington Bancshares Incorporated - Common StockSell$100,001 - $250,000filing ↗
Feb 11, 2025Mar 19, 2025SpousePEP PepsiCo, Inc. - Common StockSell$100,001 - $250,000filing ↗
Feb 11, 2025Mar 19, 2025SpouseGIS General Mills, Inc. Common StockSell$100,001 - $250,000filing ↗
Nov 12, 2024Nov 21, 2024SpouseTCMD Tactile Systems Technology IncBuy$50,001 - $100,000filing ↗
Apr 4, 2024Apr 19, 2024SpousePODD Insulet Corporation - Common StockPartial sell$50,001 - $100,000filing ↗
Apr 4, 2024Apr 19, 2024SpouseNEE Nextera EnergyPartial sell$100,001 - $250,000filing ↗

Amounts are the ranges members must report, not exact values. The STOCK Act requires a report within 45 days of a trade; "late" counts days past that deadline, measured to the filing date.

How the score breaks down

Stock self-tradinghousehold / spouse
25% weight
52
Active individual-stock trading via spouse Archie Smith (a career medical-device investor), with direct sector overlap to Smith's seat on the Senate Health (HELP) Committee. ~33 transactions since 2018; six-figure med-tech buys (Tactile Systems, Artivion) in Nov 2023, one surging ~48% post-purchase; household reportedly returned 35.4% in 2023 vs S&P ~24.8%. Elevated for volume, committee-sector overlap, suspicious timing and market-beating returns; tempered because trades are spouse's and Smith disclaims any role/knowledge, with no charges or findings.
Archie Smith bought $100K-$250K Tactile Systems (Nov 8, 2023) and $50K-$100K Artivion (Nov 10, 2023), both Minnesota-area medical-device firms; flagged as potential conflicts given Smith's Health Committee role.News reportingalphanews.org ↗Per Unusual Whales, Smith household portfolio returned 35.4% in 2023 vs the S&P 500's ~24.8%; a med-tech holding rose ~48% shortly after purchase. Smith says she has no role in her husband's investment decisions.News reportingracketmn.com ↗
Net-worth enrichment in office
15% weight
8
Net worth rose from ~$1.7M (2018) to ~$5.3M (2026, Quiver estimate). However, growth is largely attributable to her husband's pre-existing, decades-long investment career and overall market appreciation rather than demonstrable office-linked enrichment beyond salary+market. Low score reflects difficulty isolating tenure-driven gains from pre-office wealth and spousal earnings.
Quiver estimates Smith's net worth at ~$5.3M as of May 2026; 2018 estimate was ~$1.7M.Data aggregatorquiverquant.com ↗2023 disclosure shows assets $3.36M-$7.61M and liabilities $750K-$1.5M, with holdings including up to $1M DexCom and Berkshire Hathaway.Reference databaselegistorm.com ↗
Money → action alignmentcorrelation, not proof of any quid-pro-quo
20% weight
18
Correlation, not proof. Smith sits on the Senate HELP Committee with jurisdiction over health/biomedical policy, and her household is heavily invested in (and reportedly trades) medical-device and pharma-adjacent stocks; health-sector donors are recurrent contributors per OpenSecrets. No specific quid-pro-quo vote-for-dollars link is documented; the overlap of committee jurisdiction, sector investments, and industry contributions is suggestive but not proof of influence.
Smith has served on the Senate HELP (Health) Committee since 2018, which has jurisdiction over biomedical research and health legislation, overlapping with her household's med-tech investments.Data aggregatorcapitoltrades.com ↗OpenSecrets tracks Smith's industry contributions including health/pharmaceutical sector donors.Reference databaseopensecrets.org ↗
Campaign-fund personal useno data
15% weight
—
No documented FEC enforcement action, Matter Under Review, or credible reporting of campaign or leadership-PAC funds used for personal benefit was found. Absence is not penalized per rubric.
No FEC personal-use investigation or violation identified for Smith's committee; FEC committee record shows routine filings.Official recordfec.gov ↗
Revolving door & familyno data
15% weight
—
No documented family lobbying, government contracts tied to her office, or notable staff-to-lobbyist pipeline was found in public reporting. Her husband is a private investor, not a registered lobbyist on matters before her office. Absence is not penalized per rubric.
Public reporting describes Archie Smith as an independent medical-device investor, not a lobbyist; no family lobbying/contract ties to Smith's office were reported.News reportingalphanews.org ↗
Skips the job to fundraise
10% weight
5
Strong attendance: missed 69 of 3,411 roll-call votes (2.0%) from Jan 2018 to May 2026, better than the 2.8% Senate median. No reporting of heavy paid speeches or fundraising-driven absenteeism. Low score reflects a clean attendance record.
Smith missed 2.0% of roll-call votes (69 of 3,411) Jan 2018-May 2026, better than the 2.8% median for serving senators.Reference databasegovtrack.us ↗

Sources behind this score: 3 news reporting · 2 data aggregator · 3 reference database · 1 official record. Score = weighted average of the components that have data; the 2 without sourced evidence are excluded, never counted against the member. Methodology →

Embed this score on your site

Updates automatically when the score changes.

Right of reply

Is something here wrong or missing context? Members and their staff can send a correction or a statement. Statements are published on this page in full, and corrections go in the public log. Email corrections@greederboard.com.